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Leukemia in the mouse, whether induced by chemical or physical agents or 
occurring  spontaneously,  frequently  arises  in  the  thymus  (1).  This  discrete 
origin of the disease facilitates st~dy of preleukemic changes that precede overt 
tumor development. Recent work has shown striking and characteristic changes 
in  the  pattern  of cell  surface  antigens  expressed  by thymocytes during  the 
preleukemic period  in  AKR mice,  a  widely studied  strain  developing a  high 
incidence of spontaneous leukemia.  By 6 mo of age,  the surface phenotype of 
thymocytes from nonleukemic AKR mice comes to resemble the phenotype of 
thymic leukemia cells,  i.e.,  low level of Thy-1 alloantigen,  high  level of H-2 
alloantigens  (2,  3),  and  increased  expression  of a  range  of surface  antigens 
related to murine  leukemia virus  (MuLV)  (2,  4).  Parallel  assays of infectious 
MuLV  revealed  increased  levels  of xenotropic  MuLV  (but  not  of ecotropic 
MuLV)  in preleukemic  thymus  and  tests on individual  mice  showed a  close 
correlation between thymic levels of xenotropic virus and increased expression 
of MuLV antigens  (4).  Further analysis of viral isolates from preleukemic and 
leukemic AKR mice has led to the recognition of a  new class of MuLV having 
both ecotropic and xenotropic properties as well as other unusual features (5), 
and this finding may be important in defining more precisely the nature of the 
transforming virus in AKR mice. 
Just  as  AKR  mice  have  been  a  favorite  model for  analyzing  spontaneous 
leukemogenesis,  most of our knowledge  about radiation  leukemogenesis  has 
come from  the  study of C57BL mice  (6).  Mice of this  strain  develop thymic 
lymphomas with high frequency after exposure to fractionated doses of X ray. 
The causative role of virus in X-ray leukemogenesis is still unclear.  Although 
leukemogenic virus has been isolated from leukemic C57BL mice (7,  8),  most 
radiation  leukemias in this strain lack demonstrable MuLV or MuLV-related 
antigens  (9-12).  Cell surface antigens belonging to the TL (thymus-leukemia) 
system,  however,  are  frequently found on  X-ray-induced  C57BL/6 leukemias 
(13). TL antigens are specified by the Tla locus which is closely linked to the H-2 
complex on chromosome 17 (14). In normal mice, TL antigens behave as thymo- 
cyte-specific alloantigens,  being found in some strains  (TL  + strains)  and not in 
others (TL- strains),  such as C57BL/6 mice (13,  14). The unique feature of this 
system is that TL antigens may be anomalously expressed on leukemias occur- 
ring in mice of TL- strains (13,  14). This has been explained on the basis that all 
mice possess the structural gene for TL, but differ in whether they express TL 
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genetic  information  or  not.  According  to  this  view,  the  appearance  of TL  + 
leukemias  in  TL-  mice,  such  as  occur  in  C57BL/6  mice,  would result  from 
activation of the normally silent Tla locus as a consequence of leukemogenesis 
(15-17). 
Our  assumption  to  date has  been that  anomalous  TL expression  coincides 
with the transformation  event and the emergence of leukemia cells.  However, 
the preleukemic changes in alloantigens and MuLV expression in AKR thymus 
have prompted us to examine this point directly in regard to X-ray leukemogen- 
esis.  What we have asked is whether TL can be detected in the thymus of X- 
irradiated  C57BL/6 mice before the development of overt leukemia. 
Materials  and Methods 
Mice.  C57BL/6  (C57BL)  mice  were  obtained  from  The  Jackson  Laboratory,  Bar  Harbor, 
Maine. 
X-Irradiation.  6-wk-old female mice received 150 R whole body irradiation (General Electric 
Maxitron, General Electric Company,  Waterford, N. Y.) once weekly for 5 successive wk. 
Antisera.  The following typing sera were used: (a) A strain anti-EL4 (anti-H-2b), (b) (A-Thy- 
1.1 x  AKR-H-2b)F1 anti-ASL1 (anti-Thy-l.2), (c) (A-TL- × C57BL)F, anti-ASL1 (anti-TL.1,2), and 
(d) C57BL-TL + anti-ERLD (anti-TL.4). The polyvalent antiserum to MuLV is (W/Fu x  BN)F1 rat 
anti-W/Fu leukemia  (C58NT)D.  This antiserum,  which has been extensively studied,  detects a 
broad range of MuLV-related antigens (2, 4,  10,  11,  18, 19). 
Serological Techniques.  For details of the cytotoxic test and absorption procedures,  see pre- 
vious publications from this laboratory (9,  11,  19). 
Results 
From past experience with the schedule of irradiation  used in these experi- 
ments,  >95% C57BL female mice (6 wk old at the time of initial X ray) develop 
leukemia,  predominantly  of thymic origin.  In a  recent series of 40 mice,  the 
average latent period for overt leukemia development is 153 days (range 90-225) 
after the last course of X ray. 
Expression of H-2, Thy-1, TL, and MuL V Antigens on Thymocytes  of  Irradi- 
ated Mice.  Fig. 1 shows cytotoxic tests with thymocytes from individual C57BL 
mice 28-38 days after the last course of X ray. For comparison, thymocytes from 
normal  C57BL mice  (phenotype  H-2  b,  Thy-l.2,  TL-,  G~-)  of similar  age  are 
included.  The trend toward a  higher  level of H-2 alloantigens  and  a  reduced 
level of Thy-l.2 alloantigen  is consistent with the preleukemic changes previ- 
ously reported for AKR mice and irradiated C57BL mice (2, 3). TL  + thymocytes 
were detected in a  high proportion of the irradiated  mice, with the number of 
TL  + cells in individual thymuses ranging from 20 to 95%. Fig. 2 summarizes the 
results  of TL tests over the  53-day postirradiation  period and  shows that  TL 
antigen was found in the thymus of 30 of 49 mice. Typing with anti-TL.4 or with 
anti-TL.1,2  antisera gave similar results,  indicating  concomitant preleukemic 
expression of TL specificites characteristically found on C57BL leukemias. Figs. 
1 and 2 also show reactions with the polyvalent anti-MuLV antiserum.  Accord- 
ing to these tests,  low to  moderate  levels of MuLV  antigen  expression were 
found on thymocytes of 20 of 42 irradiated  mice. 
No  sign  of overt  leukemia  was  noted  in  irradiated  mice  during  the  time 
interval of this study. The size of TL  + cells did not differ from the predominant 
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FIG.  1.  Expression of It-2, Thy-1, TL, and MuLV antigens on thymocytes of C57BL mice 
28-38 days after last exposure to X ray. Each line represents cytotoxic tests with thymocytes 
from an individual donor. Heavy line: thymocytes from control, nonirradiated C57BL mice. 
section of selected thymuses revealed no evidence for the presence of leukemia 
cells. No correlation was noted between thymic weight and TL or MuLV antigen 
expression. 
Absorption Tests for TL.1 and Gzx (MuL V) Antigens.  To confirm the speci- 
ficity of TL  and  MuLV  reactions,  absorption  tests  were  performed  for  TL.1 
antigen  (14) and for Gtx, a  type-specific antigen of the gp70 envelope glycopro- 
tein of MuLV (11, 18, 20). There was a clear parallel between the results of direct 
cytotoxic tests and the absorption capacity of the same cell population. 
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FIG.  3.  Relation between TL and MuLV antigen expression on preleukemic thymocytes. 
Thymocytes from individual C57BL mice  (10-53 days after last exposure to X  ray)  were 
typed with anti-TL and anti-MuLV. No correlation between TL and MuLV antigen expres- 
sion is evident. 
thymocytes from individual  mice with anti-TL  and anti-MuLV are plotted  in 
Fig. 3. No apparent correlation exists between the expression of TL and MuLV 
antigens. 
Discussion 
The results indicate that activation of the Tla locus occurs during the preleu- 
kemic phase of radiation  leukemogenesis.  Individual  mice show considerable 
variability with regard to the time this genetic event takes place, and it should 
be possible, by using thymic biopsy, to determine whether early appearance of 
TL  correlates  with  early  development  of leukemia.  Experiments  involving 
transfer  of bone  marrow  to  lethally  irradiated  recipients  should  also resolve 
whether  the  X-ray-induced  TL-  --*  TL  + conversion  is  due  to changes  in the 
precursor cells of bone marrow origin that repopulate the thymus or to changes 
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differentiation.  Much work has been done by Kaplan (6) defining  optimal 
conditions  for  leukemia induction  by X ray  and it  will  be  interesting  to  see  ifTL 
induction  by X ray follows  the same rules.  Chemical agents,  such as urethan 
and  carcinogenic  polycyclic  hydrocarbons, are  also  known to  be  leukemogenic in 
C57BL mice,  and we are now testing  these agents for  TL-inducing activity. 
The considerable number of mice showing MuLV  antigen expression  on 
thymocytes  during  the  preleukemic  phase  is  somewhat surprising.  C57BL radia- 
tion-induced  leukemias  rarely  express MuLV-related surface  antigens (9-12);  in 
a recent  survey of  24 C57BL leukemias for  the two major cell  surface  determi- 
nants specified  by MuLV, GCSA  (9),  and G~ (11),  21 leukemias were GCSA- 
G~-, 2 were GCSA+GIx  +, and 1 was GCSA+Gcc.  To explain this difference 
between MuLV  expression in preleukemic and leukemic cells,  we can assume 
that MuLV  is activated only transiently  and at very low levels  during the 
preleukemic period,  and it  would be at  this  time,  and not after  overt  leukemia 
development, that infectious  virus  might be most easily  isolated.  The work of 
Haran-Ghera  (8) and Haas  (21)  gives considerable support to this  idea. A 
question  that  has been repeatedly  asked since  the discovery  of  TL concerns the 
role  of  MuLV  in the anomalous expression  of  TL in leukemias. The possibility 
that the Tla locus  may represent the integration  site  of a defective  MuLV 
genome appears  unlikely  in  view  of  the  close  structural  similarities  between  the 
TL product and the products of  the closely  linked  H-2 complex (22).  Another 
possibility  is that MuLV, directly  or indirectly,  activates  the Tla locus.  Since 
leukemias known to  be MuLV-induced are  frequently  TL- (14),  TL activation  is 
clearly not an invariable consequence of MuLV  infection,  but would be re- 
stricted  to a special  class  of  MuLV. The lack  of  any direct  correlation  between 
TL and MuLV  expression  on  preleukemic  thymocytes tells  against  this  possibil- 
ity,  although the association  may be too complex to show up in  this  way. 
Summary 
Anomalous appearance of TL (thymus-leukemia) antigens is a characteristic 
feature of radiation-induced leukemias of C57BL/6 mice.  We now report that 
thymocytes of irradiated C57BL/6 mice  express TL antigens long before the 
development of overt leukemia. Thus, TL is a marker for preleukemic changes 
occurring during radiation leukemogenesis.  Low levels  of murine  leukemia 
virus  (MuLV)-related antigens are also detected on preleukemic thymocytes. 
Comparative tests on individual mice show no direct correlation between TL and 
MuLV antigen expression. 
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